Found: 26
Select item for more details and to access through your institution.
Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Business challenges for disabled poor women in rural Bangladesh.
- Published in:
- Rural 21, 2021, v. 55, n. 2, p. 46
- By:
- Publication type:
- Article
Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1665, doi. 10.3390/jcm10081665
- By:
- Publication type:
- Article
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29684-9
- By:
- Publication type:
- Article
Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090948
- By:
- Publication type:
- Article
The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 4, p. 1, doi. 10.1111/jne.13376
- By:
- Publication type:
- Article
Neuroendocrine neoplasms: Consensus on a patient care pathway.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 4, p. 1, doi. 10.1111/jne.13380
- By:
- Publication type:
- Article
"Money does not understand disability": Barriers to microfinance for people with disabilities in Bangladesh.
- Published in:
- Asian Social Work & Policy Review, 2024, v. 18, n. 3, p. 1, doi. 10.1111/aswp.12318
- By:
- Publication type:
- Article
"We'll starve to death": The consequences of COVID‐19 over the lives of poor people with disabilities in rural Nepal.
- Published in:
- Asian Social Work & Policy Review, 2022, v. 16, n. 2, p. 96, doi. 10.1111/aswp.12250
- By:
- Publication type:
- Article
Next-generation sequencing and molecular therapy.
- Published in:
- Clinical Medicine, 2023, v. 23, n. 1, p. 65, doi. 10.7861/clinmed.2022-0514
- By:
- Publication type:
- Article
Tubulin β- III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
- Published in:
- Histopathology, 2014, v. 65, n. 6, p. 784, doi. 10.1111/his.12497
- By:
- Publication type:
- Article
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 9, p. 795, doi. 10.1007/s40261-021-01063-0
- By:
- Publication type:
- Article
Quinone Oxidoreductase-2-Mediated Prodrug Cancer Therapy.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 40, p. 1, doi. 10.1126/scitranslmed.3000615
- By:
- Publication type:
- Article
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 38, doi. 10.1038/s41416-023-02279-x
- By:
- Publication type:
- Article
Revitalising cancer trials post-pandemic: time for reform.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 8, p. 1409, doi. 10.1038/s41416-023-02224-y
- By:
- Publication type:
- Article
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
- Published in:
- 2023
- By:
- Publication type:
- journal article
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Apoptosis in the Pancreatic Cancer Tumor Microenvironment—The Double-Edged Sword of Cancer-Associated Fibroblasts.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1653, doi. 10.3390/cells10071653
- By:
- Publication type:
- Article
Exploring the Effect of PAK Inhibition in a 3D Pancreatic Cancer Invasion Model †.
- Published in:
- Biology & Life Sciences Forum, 2023, v. 21, n. 1, p. 32, doi. 10.3390/blsf2023021032
- By:
- Publication type:
- Article
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4585, doi. 10.1002/cncr.33870
- By:
- Publication type:
- Article
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00263
- By:
- Publication type:
- Article
Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18636-w
- By:
- Publication type:
- Article